Show simple item record

dc.contributor.authorStudd, JB
dc.contributor.authorCornish, AJ
dc.contributor.authorHoang, PH
dc.contributor.authorLaw, P
dc.contributor.authorKinnersley, B
dc.contributor.authorHoulston, R
dc.date.accessioned2022-02-01T16:14:17Z
dc.date.available2022-02-01T16:14:17Z
dc.date.issued2021-11-09
dc.identifier.citationBlood cancer journal, 2021, 11 (11), pp. 177 - ?
dc.identifier.issn2044-5385
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4990
dc.identifier.eissn2044-5385
dc.identifier.eissn2044-5385
dc.identifier.doi10.1038/s41408-021-00570-9
dc.identifier.doi10.1038/s41408-021-00570-9
dc.description.abstractTo obtain a comprehensive picture of composite genetic driver events and clonal dynamics in subtypes of paediatric acute lymphoblastic leukaemia (ALL) we analysed tumour-normal whole genome sequencing and expression data from 361 newly diagnosed patients. We report the identification of both structural drivers, as well as recurrent non-coding variation in promoters. Additionally we found the transcriptional profile of histone gene cluster 1 and CTCF altered tumours shared hallmarks of hyperdiploid ALL suggesting a 'hyperdiploid like' subtype. ALL subtypes are driven by distinct mutational processes with AID mutagenesis being confined to ETV6-RUNX1 tumours. Subclonality is a ubiquitous feature of ALL, consistent with Darwinian evolution driving selection and expansion of tumours. Driver mutations in B-cell developmental genes (IKZF1, PAX5, ZEB2) tend to be clonal and RAS/RTK mutations subclonal. In addition to identifying new avenues for therapeutic exploitation, this analysis highlights that targeted therapies should take into account composite mutational profile and clonality.
dc.formatElectronic
dc.format.extent177 - ?
dc.languageeng
dc.language.isoeng
dc.publisherSPRINGERNATURE
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleCancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes.
dc.typeJournal Article
dcterms.dateAccepted2021-10-27
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1038/s41408-021-00570-9
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2021-11-09
dc.relation.isPartOfBlood cancer journal
pubs.issue11
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.publication-statusPublished
pubs.volume11
pubs.embargo.termsNot known
icr.researchteamCancer Genomics
dc.contributor.icrauthorStudd, James
dc.contributor.icrauthorCornish, Alexander
dc.contributor.icrauthorLaw, Philip
dc.contributor.icrauthorKinnersley, Benjamin
dc.contributor.icrauthorHoulston, Richard


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/